Medical devices, healthcare technology and the business of care
510(k) clearance · K260144

Reclining wheelchair (YJ-013L)

Zhenjiang Assure Medical Equipment Co., Ltd. · Decision date Sep 15, 2026

MEDTECHLEDGER EXPLANATIONK260144

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 2026-09-15 for Reclining wheelchair (YJ-013L), submitted by Zhenjiang Assure Medical Equipment Co., Ltd. of Zhenjiang, China, under 510(k) number K260144. The device falls under regulation 890.3850 with classification product code IOR and the classification name Wheelchair, Mechanical; the regulation medical specialty and review panel are both Physical Medicine. The application was received on 01/20/2026.

SESE denotes 510(k) clearance to market, not premarket approval of a new device. The record lists a Special summary, no third-party review, no combination product status, and no authorized predetermined change control plan. The page does not identify specific components, design changes, predicate devices, or performance data supporting the equivalence finding; those details would reside in the underlying 510(k) submission rather than this summary record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Sep 15, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260144
Regulatory pathway
510(k) premarket notification
Product code
IOR
Decision code
SESE
Decision date
Sep 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wheelchair, Mechanical.

Product code
IOR
FDA device class
1

FDA decision timeline

  1. K260144 received

    Application receipt date recorded by FDA.

  2. K260144 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IOR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zhenjiang Assure Medical Equipment Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Zhenjiang City

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records